Director of Resmed board resigns
Tuesday, 10 June, 2008
A director of the Resmed (ASX: RMD) board has resigned, reducing the number of board members to eight.
Donagh McCarthy, president of the renal division of Baxter Healthcare in the US, has declined to stand for re-election to the board.
The remaining board members decided that instead of finding a replacement for McCarthy, the board would be reduced to eight.
Resmed founder Dr Peter Farrell will continue to hold the post of executive director of the board.
Farrell had previously arranged to become non-executive chairman by June 30.
Scientists find new driver of ovarian cancer spread
A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
